REGISTERED
on 28 May 2024
Last Applicant/ Owned by
Frankfurter Str. 250
64293 Darmstadt
DE
F128/002
Serial Number
97712953 filed on 12th Dec 2022
Registration Number
7395725 registered on 28th May 2024
Correspondent Address
William C. Wright
Filing Basis
1. intent to use
Disclaimer
NO DATA
AMPTEC
Quality control for others, namely, conducting of quality control tests for manufacture of nucleic acids for research and therapeutic use; Consumer product safety testing for manufacture of nucleic acids for research and therapeutic use; Process monitoring for quality assurance for manufacture of nucleic acids for research and therapeutic use; Product quality testing services for manufacture of nu Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Quality control for others, namely, conducting of quality control tests for manufacture of nucleic acids for research and therapeutic use; Consumer product safety testing for manufacture of nucleic acids for research and therapeutic use; Process monitoring for quality assurance for manufacture of nucleic acids for research and therapeutic use; Product quality testing services for manufacture of nucleic acids for research and therapeutic use; Product safety testing services for manufacture of nucleic acids for research and therapeutic use; Quality control for others, namely, providing quality assurance services for manufacture of nucleic acids for research and therapeutic use; Quality control of goods and services for manufacture of nucleic acids for research and therapeutic use; Scientific and technological services, namely, testing in the field of manufacture of nucleic acids for research and therapeutic use; Testing of pharmaceuticals; Testing of biologics in the nature of pharmaceuticals; Testing of biopharmaceuticals; Testing of raw materials; Development of pharmaceuticals preparations and medicines, namely, manufacture of nucleic acids for therapeutic use; Pharmaceutical drug development services for manufacture of nucleic acids for therapeutic use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemical and biochemical products for industrial, scientific or therapeutic purposes in the fields of pharmacy, biology, molecular biology, biochemistry, biotechnology and chemistry, including food chemistry, namely, chemicals for use in biotechnological product development; Chemical preparations and reagents, other than for medical or veterinary purposes, in particular, nucleic acid modifying enzymes and nucleic acid reagents; Diagnostic preparations other than for medical or veterinary purposes for molecular biology research and diagnostics, including research and diagnostic preparations containing the aforementioned reagents alone or in combination with other reagents as assemblies in the nature of consisting primarily of buffers, reagent components as part of kits or assemblies containing nucleic acids, for the processing or therapeutic application of pathogenic and non-pathogenic microorganisms and of nucleic acid molecules
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Custom manufacture of biopharmaceuticals; Custom manufacture of pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97712953
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 28th May 2024 | REGISTERED-PRINCIPAL REGISTER |
| 12th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Mar 2024 | PUBLISHED FOR OPPOSITION |
| 21st Feb 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 21st Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 06th Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 05th Feb 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 05th Feb 2024 | EXAMINERS AMENDMENT E-MAILED |
| 05th Feb 2024 | EXAMINERS AMENDMENT -WRITTEN |